ARK Genomic Revolution ETF vs Avantis International Small Cap Value ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.55, while Avantis International Small Cap Value ETF trades at $110.4. Which is the better fit depends on your goals.
| ARKG | AVDV | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $44.55 | $110.40 |
52-Week Low | $24.02 | $83.89 |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →AVDV is an actively managed ETF that targets small-cap value companies in developed markets outside the United States. It uses a systematic, rules-based process to identify firms trading at low valuations with high profitability, aiming to capture the 'size' and 'value' premiums while maintaining broad diversification.
Read more on AVDV →